8-Methyl-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95+%, 100mg

E-plan EPLi 10x/0.25 IOS infinity corrected objective

6-Methyl-4-(trifluoromethyl)nicotinonitrile, 95.0%, 250mg

5-Sulfamoylfuran-2-carboxylic acid, 97.0%, 5g

Benzyl 3-formylazetidine-1-carboxylate, 97+%, 100mg

4-Bromo-1-(tert-butyl)-5-phenyl-1H-pyrazole, 95.0%, 250mg

3-(ethoxycarbonyl)-1-(4-ethylphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

3-(1H-Benzoimidazol-2-yl)-phenol, 5g

5-benzyl-4-cyclohexyl-4H-1,2,4-triazole-3-thiol, 5g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 1.00 µm, 1 Piece(s)

1-ethylbenzo[cd]indol-2(1H)-one, 95.0%, 1g

2-Bromo-4-chloro-5-methylpyridine, 95.0%, 250mg

3-allyl-6-(methylsulfonyl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 250mg